Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiajian Guishen Formulation in Premature Ovarian Insufficiency
NCT06102655Phase 1Completed
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 1, open-label trial of Jiajian Guishen Formulation in premature ovarian insufficiency (POI) (2 arms). Primary endpoint: Follicle Stimulating Hormone. Started Jul 2023; status: completed.
02
Drugs
Jiajian Guishen Formulation
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT06102655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06102655.